FOR IMMEDIATE RELEASE
DRESNER PARTNERS ADVISES DIALYSIS CORPORATION OF AMERICA, INC. ON ITS SALE TO U.S. RENAL CARE, INC.
CHICAGO – June 9, 2010 – Dresner Partners, a leading FINRA-registered, middle-market investment bank and IMAP member, advised Dialysis Corporation of America, Inc. (DCA)(NASDAQ: DCAI) on its recently completed sale to U.S. Renal Care, Inc. (USRC). Headquartered in Linthicum, Maryland, DCA is a leading regional provider of outpatient dialysis services in the Eastern and Midwestern U.S., operating 37 dialysis centers and 11 acute programs across seven states. With the acquisition, Plano, Texas-based USRC will operate 84 dialysis facilities as well as home and acute programs across nine states, providing care to roughly 5,500 End Stage Renal Disease (ESRD) patients in Arkansas, Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, Texas, and Virginia. The $110.25 million transaction, announced on April 14th, was completed on June 3rd.
“I am very proud of the business we built at DCA,” said Thomas K. Langbein, former chairman of the board of DCA. “I thank our shareholders who can be proud to have been part of DCA’s success. I thank our employees and our physicians for contributing to our growth and success. Given the compatibilities of the two companies, the integration of DCA with USRC will be a smooth and efficient transition. With shared values and a mission to provide best-in-class renal care, USRC and DCA are well-matched.”
Stephen Everett, former president and CEO of DCA, added, “As a company, we put the needs of our patients first. This philosophy has fueled our growth. I am grateful to the physicians and employees of DCA who ensured the company never lost sight of our patient-centric values. USRC is the perfect match for DCA’s culture, philosophy, and commitment to exemplary patient care. There is no doubt that the future is bright for USRC, our combined physicians and staff.”
Dresner Partners served as the exclusive financial advisor to DCA and provided a fairness opinion to DCA’s board in connection with the transaction.
About Dialysis Corporation of America, Inc.
Dialysis Corporation of America, Inc., a leading regional provider of dialysis services to patients suffering from End Stage Renal Disease (ESRD), owns and operates freestanding kidney hemodialysis centers located in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysis services on a contract basis to certain hospitals located in those states. The company operates 37 centers and provides in-center, acute, and home dialysis to over 2,000 ESRD patients. Information on DCA can be found at www.dialysiscorporation.com.
About U.S. Renal Care, Inc.
Founded in 2000 in Arkansas by an experienced team of healthcare executives, U.S. Renal Care, Inc. is recognized as a leader in establishing joint ventures with nephrologists for the operation of outpatient treatment centers for individuals suffering from chronic kidney failure. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis and peritoneal dialysis services. U.S. Renal Care operates dialysis programs in Arkansas, Texas, Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia. USRC’s outside investors include SV Life Sciences, Cressey & Company, Salix Ventures, and Select Capital Ventures. For more information on U.S. Renal Care, Inc. please visit www.usrenalcare.com
About Dresner Partners
Dresner Partners is a FINRA-registered, middle-market investment bank headquartered in Chicago, Illinois. Founded in 1991, Dresner Partners provides financial advisory services to business owners and managers throughout the world, including institutional private placements of debt and equity, merger and acquisitions, valuations and strategic consulting services. Dresner Partners is also a member of IMAP, an exclusive global organization of leading merger and acquisition advisory firms. Its affiliate company, Dresner Corporate Services, is a strategic communications firm specializing in public and investor relations. More information is available at www.dresnerpartners.com or www.imap.com/locations/office.cfm?OfficeID=416.
# # #
For Media Inquiries:
Stephen Mullin, (312) 780-7213, email@example.com